Birgitte Bentz Damholt

Author

Also Known As

B. Damholt, Birgitte Bentz Damholt, Birgitte Damholt

Publications

588

Citations

H-Index

Concepts

All Affiliations

Birgitte Bentz Damholt is an author at Novo Nordisk (Denmark) specializing in diabetes, metabolic syndrome, and pharmacotherapy.

#	Concept	H-Index	Publications	Citations
1	Health Sciences	1	1	78
2	Medicine	1	1	78
3	Diabetes	1	1	78
4	Endocrinology	1	1	78
5	Pharmacology	1	1	78

Birgitte Bentz Damholt

Publications

565

Citations

H-Index

Page 1

	Year	Citations
Albumin‐bound basal insulin analogues (insulin detemir and NN344): comparable time‐action profiles but less variability than insulin glargine in type 2 diabetes Oliver Klein, Jan Lynge, Lars Endahl, Diabetes Obesity and Metabolism	2006	252
Engineered phage with antibacterial CRISPR–Cas selectively reduce E. coli burden in mice Yilmaz Emre Gençay, Camille Robert, Szabolcs Semsey, Nature Biotechnology	2023	210
An Open‐Label, Parallel Group Study Investigating the Effects of Age and Gender on the Pharmacokinetics of the Once‐Daily Glucagon‐Like Peptide‐1 Analogue Liraglutide Birgitte Bentz Damholt, Georg Golor, W Wierich, The Journal of Clinical Pharmacology AgingElderly SubjectsPeptide TherapeuticsPharmacotherapyMetabolic Syndrome	2006	78
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Macimorelin in Children with Suspected Growth Hormone Deficiency: An Open-Label, Group Comparison, Dose-Escalation Trial Violetta Csákváry, Nicola Ammer, Ekaterine Bakhtadze Bagci, Hormone Research in Paediatrics	2021	14
Absorption, metabolism and excretion of once-weekly somapacitan, a long-acting growth hormone derivative, after single subcutaneous dosing in human subjects Hans Helleberg, Mads Bjelke, Birgitte Bentz Damholt, European Journal of Pharmaceutical Sciences	2021	11

Page 1